- External beam radiotherapy – X-rays are given from outside your body, using a radiotherapy machine.
- Internal radiotherapy – a small amount of radioactive material is placed inside your body to treat cancers in your internal organs.
Both types can be given as outpatient procedures, or are carried out as part of wider inpatient cancer treatments.
Varian Edge
The Varian Edge provides very precise radiotherapy. It is designed for stereotactic brain and spinal radiosurgery, as well as stereotactic ablative radiotherapy (SABR) – which is used for small tumours elsewhere in the body – and intensity modulated radiotherapy, a highly versatile treatment for a wide range of cancer types.
Gamma Knife Icon
Stereotactic radiosurgery (SRS) is an effective treatment for single and multiple brain metastases, which can occur as secondary tumours in patients with cancers such as melanoma, breast, and lung cancers. SRS uses powerful beams of radiation to destroy cancer cells in a few short treatments. It is often called ‘brain-sparing’ surgery because of its ability to protect healthy brain tissue and preserve quality of life in people needing treatment for brain tumours.
The new Gamma Knife Icon is one of the most advanced systems for this type of intracranial (brain) surgery. Gamma Knife Icon is also used to treat benign brain tumours such as meningiomas, acoustic neuromas and primary pituitary tumours, and other non-cancerous brain conditions.
MRIdian MR Linac
Cromwell Hospital is the first hospital in London and the second in the UK to use MRI-guided Linac technology. The MRI-guided Linac is a technological step change in radiotherapy that significantly improves outcomes through more precise targeting of tumours, including those of the pancreas, liver, lung, prostate, and breast.
The MRIdian is a state-of-the-art system that combines an MRI scanner with a radiotherapy machine, thus enabling the exact position and shape of the tumour to be seen throughout the treatment, resulting in heightened targeting and accuracy. With improved accuracy, there is less damage to surrounding healthy tissue and subsequently reduced side effects. For most patients, it will also reduce the number of treatment sessions by half.
Clinical interests: Urological cancer and neuro-oncology.
Languages spoken: English
Dr Andrew Gaya
/ Consultant Clinical Oncologist
Clinical oncology, Brain/CNS, Colon, Hepatobiliary, Lower GI, Upper GI
Clinical interests: Gastrointestinal cancers (oesophagus, stomach, liver, pancreas, colon, rectum, anal); stereotactic radiotherapy and radiosurgery (Gamma Knife Icon, CyberKnife, MRIdian MR Linac); chemotherapy, biological therapy, and immunotherapy; molecular and genetic profiling of cancers.
Languages spoken: English
Clinical interests: Prostate, bladder, kidney, testis, penile cancer
Languages spoken: English
Clinical interests: Breast, GI, lung and general oncology
Languages spoken: English
Clinical interests: Urological cancer, chemoradiotherapy for lung cancer
Languages spoken: English
Clinical interests: Lymphomas, gastrointestinal, lung malignancies
Languages spoken: Arabic/English
Clinical interests: Management of thyroid cancer, radioiodine and targeted therapies (tyrosine kinase inhibitors). Management of head and neck cancers using radiotherapy and chemotherapy.
Languages spoken: English
Clinical interests: Head and Neck Cancer, Thyroid Cancer, Lung Cancer, Cyberknife, Proton Beam Therapy, Chemotherapy
Languages spoken: English
Clinical interests: Breast, brain, endocrine, and urological cancers; stereotactic radiotherapy (CyberKnife and GammaKnife).
Languages spoken: English
Languages spoken: English
